Pedersen, M. N., Hybel, T. E., Bjerre, J. H., Hammer, A. S. B., Bohn, A. B., Bill, M., Rosenberg, C. A. & Ludvigsen, M. (2025). High-Efficiency Enrichment of Megakaryocytes and Identification of Micromegakaryocytes from Human Bone Marrow by Imaging Flow Cytometry. Cells, 14(8), Article 588. https://doi.org/10.3390/cells14080588

Andersen, M. D., Wolter, K., Enemark, M. H., Lauridsen, K. L., Hamilton-Dutoit, S. J., Starklint, J., d’Amore, F., Ludvigsen, M., Honoré, B. & Kamper, P. (2025). Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity. Leukemia & Lymphoma, 66(4), 656-667. https://doi.org/10.1080/10428194.2024.2434170

Andersen, M. D., Wolter, K., Enemark, M. B. H., Pedersen, M. A., Gormsen, L. C., Lauridsen, K. L., Starklint, J., Hamilton-Dutoit, S. J., d'Amore, F., Ludvigsen, M., Honoré, B. & Kamper, P. (2025). Proteomic Profiling of Lymph Nodes Differentiates Classic Hodgkin Lymphoma With and Without Skeletal Involvement. European Journal of Haematology, 114(1), 173-185. https://doi.org/10.1111/ejh.14326

Sorensen, E. F., Hybel, T. E. & Ludvigsen, M. (2025). Response to correspondence piece on 'Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes'. AIDS, 39(4), 481-481. https://doi.org/10.1097/QAD.0000000000004139

MacManus, M. P., Seymour, J. F., Tsang, H., Fisher, R., Keane, C., Sabdia, M. B., Law, S. C., Gunawardana, J., Nath, K., Kazakoff, S. H., Marques-Piubelli, M. L., Duenas, D. E., Green, M. R., Roos, D., O'Brien, P., McCann, A., Tsang, R., Davis, S., Christie, D. ... Tobin, J. W. D. (2024). Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma. EBioMedicine, 110, Article 105468. https://doi.org/10.1016/j.ebiom.2024.105468

Urbonavicius, S., Srinanthalogen, R., Sandermann, J., Valius, M., Kaupinis, A. & Ludvigsen, M. (2024). A novel view to varicose veins pathogenesis: Proteomic profiling suggests a pivotal role of extracellular matrix degradation. Phlebology, 39(1), 20-28. https://doi.org/10.1177/02683555231206891

Hybel, T. E., Sørensen, E. F., Enemark, M. H., Hemmingsen, J. K., Simonsen, A. T., Lauridsen, K. L., Møller, M. B., Pedersen, C., Pedersen, G., Obel, N., Larsen, C. S., d'Amore, F., Hamilton-Dutoit, S., Stougaard, M., Vase, M. Ø. & Ludvigsen, M. (2024). Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes. AIDS, 38(14), 1897-1906. https://doi.org/10.1097/QAD.0000000000003996

Rosenberg, C. A., Rodrigues, M. A., Bill, M. & Ludvigsen, M. (2024). Comparative analysis of feature-based ML and CNN for binucleated erythroblast quantification in myelodysplastic syndrome patients using imaging flow cytometry data. Scientific Reports, 14(1), Article 9349. https://doi.org/10.1038/s41598-024-59875-x

Holst, J. M., Pedersen, M. B., Enemark, M. B., Hansen, M. C., Noerhave, P. R., Plesner, T. L., Frederiksen, H., Moeller, M. B., Hamilton-Dutoit, S. J., Noergaard, P., Mortensen, B. K., Ommen, H. B., Stentoft, J., Tam, W., Ludvigsen, M., Chan, W. C., Birkbak, N. J., Inghirami, G. & d’Amore, F. (2024). Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma. Haematologica, 109(12), 4067-4072. https://doi.org/10.3324/haematol.2023.283798

Enemark, M. H., Wolter, K., Hybel, T. E., Andersen, M. D., Sørensen, E. F., Hindkaer, L. M., Lauridsen, K. L., Madsen, C., Plesner, T. L., Hamilton-Dutoit, S. & Honoré, B. (2024). Differential tumor protein expression at follicular lymphoma diagnosis reveals dysregulation of key molecular pathways associated with histological transformation. Scientific Reports, 14(1), Article 29962. https://doi.org/10.1038/s41598-024-81693-4

Shelton, V., Detroja, R., Liu, T., Isaev, K., Silva, A., Passerini, V., Bakhtiari, M., Calvente, L., Hong, M., He, M. Y., Modi, S., Hershenfeld, S. A., Ludvigsen, M., Madsen, C., Hamilton-Dutoit, S., d’Amore, F. A., Brodtkorb, M., Johnson, N. A., Baetz, T. ... Kridel, R. (2024). Identification of genetic subtypes in follicular lymphoma. Blood Cancer Journal, 14(1), Article 128. https://doi.org/10.1038/s41408-024-01111-w

Hybel, T. E., Jensen, S. H., Rodrigues, M. A., Hybel, T. E., Pedersen, M. N., Qvick, S. H., Enemark, M. H., Bill, M., Rosenberg, C. A. & Ludvigsen, M. (2024). Imaging Flow Cytometry and Convolutional Neural Network-Based Classification Enable Discrimination of Hematopoietic and Leukemic Stem Cells in Acute Myeloid Leukemia. International Journal of Molecular Sciences , 25(12), Article 6465. https://doi.org/10.3390/ijms25126465

Enemark, M. H., Jensen, M. L., Andersen, M. D., Plesner, T. L., Hamilton-Dutoit, S. & Ludvigsen, M. (2024). Impact of the Immune Landscape in Follicular Lymphoma: Insights into Histological Transformation in the Rituximab Era. Cancers, 16(20), Article 3553. https://doi.org/10.3390/cancers16203553

Enemark, M. H., Hemmingsen, J. K., Jensen, M. L., Kridel, R. & Ludvigsen, M. (2024). Molecular Biomarkers in Prediction of High-Grade Transformation and Outcome in Patients with Follicular Lymphoma: A Comprehensive Systemic Review. International Journal of Molecular Sciences , 25(20), Article 11179. https://doi.org/10.3390/ijms252011179

Enemark, M. H., Hemmingsen, J. K., Andersen, M. D., Hybel, T. E., Bjørn, M. E., Josefsson, P. L., Pedersen, L. M., Juul, M. B., Pedersen, R. S., Thorsgaard, M., Sillesen, I. B., Plesner, T. L., Hamilton-Dutoit, S. J., Jensen, P., Madsen, C. & Ludvigsen, M. (2024). Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort. Blood Cancer Journal, 14(1), 167. Article 167. https://doi.org/10.1038/s41408-024-01150-3

Hemmingsen, J. K., Enemark, M. H., Sørensen, E. F., Lauridsen, K. L., Hamilton-Dutoit, S. J., Kridel, R., Honoré, B. & Ludvigsen, M. (2024). Proteomic Profiling Identifies Predictive Signatures for Progression Risk in Patients with Advanced-Stage Follicular Lymphoma. Cancers, 16(19), Article 3278. https://doi.org/10.3390/cancers16193278

Hershenfeld, S. A., Tobin, J. W. D., Shelton, V., Calvente, L., Lajkosz, K., Liu, T., Brodtkorb, M., d'Amore, F. A., Ludvigsen, M., Baetz, T., LeBrun, D., Johnson, N., Crump, M., Hong, M., Kuruvilla, J., Tremblay-LeMay, R., MacManus, M., Tsang, R., Hodgson, D. C. ... Kridel, R. (2024). Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy. British Journal of Haematology, 205(5), 1810-1814. https://doi.org/10.1111/bjh.19698

Neldeborg, S., Soerensen, J. F., Møller, C. T., Bill, M., Gao, Z., Bak, R. O., Holm, K., Sorensen, B., Nyegaard, M., Luo, Y., Hokland, P., Stougaard, M., Ludvigsen, M. & Holm, C. K. (2023). Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo. Leukemia, 37(9), 1792-1801. https://doi.org/10.1038/s41375-023-01950-9

Enemark, M. B. H., Sørensen, E. F., Hybel, T. E., Andersen, M. D., Madsen, C., Lauridsen, K. L., Honoré, B., d'Amore, F., Plesner, T. L., Hamilton-Dutoit, S. J. & Ludvigsen, M. (2023). IDO1 Protein Is Expressed in Diagnostic Biopsies from Both Follicular and Transformed Follicular Patients. International Journal of Molecular Sciences , 24(8), Article 7314. https://doi.org/10.3390/ijms24087314

Beck Enemark, M., Wolter, K., Campbell, A. J., Andersen, M. I. D., Sørensen, E. F., Hybel, T. E., Madsen, C., Lauridsen, K. L., Plesner, T. L., Hamilton-Dutoit, S. J., Honoré, B. & Ludvigsen, M. (2023). Proteomics identifies apoptotic markers as predictors of histological transformation in patients with follicular lymphoma. Blood Advances, 7(24), 7418-7432. https://doi.org/10.1182/bloodadvances.2023011299